Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine
Natalie McCormick(Research Canada), Hyon K. Choi(Massachusetts General Hospital), Zachary S. Wallace(Amgen (United States)), April Jorge(Massachusetts General Hospital), Chana A. Sacks(Harvard University), Chio Yokose(Brown University), John Hsu(Kaiser Permanente)
Cited by 11
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
|New England Journal of Medicine|2004|1.2k
Alcohol intake and risk of incident gout in men: a prospective study
|The Lancet|2004|748
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
|The American Journal of Medicine|2012|661
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574